Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Neuroone Medical Technologies (NMTC) over the last 8 years, with Q4 2025 value amounting to $4806.0.

  • Neuroone Medical Technologies' Gains from Investment Securities rose 10123.41% to $4806.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $4806.0, marking a year-over-year increase of 10200.59%. This contributed to the annual value of $6.1 million for FY2025, which is 11616.77% up from last year.
  • Latest data reveals that Neuroone Medical Technologies reported Gains from Investment Securities of $4806.0 as of Q4 2025, which was up 10123.41% from $314751.0 recorded in Q3 2025.
  • Neuroone Medical Technologies' 5-year Gains from Investment Securities high stood at $1.2 million for Q1 2024, and its period low was -$390351.0 during Q1 2025.
  • Over the past 5 years, Neuroone Medical Technologies' median Gains from Investment Securities value was -$4074.0 (recorded in 2021), while the average stood at $117937.7.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first skyrocketed by 183155.82% in 2023, then tumbled by 297222.51% in 2024.
  • Over the past 5 years, Neuroone Medical Technologies' Gains from Investment Securities (Quarter) stood at -$26235.0 in 2021, then soared by 471.78% to $97536.0 in 2022, then tumbled by 86.1% to $13559.0 in 2023, then plummeted by 2972.23% to -$389445.0 in 2024, then surged by 101.23% to $4806.0 in 2025.
  • Its last three reported values are $4806.0 in Q4 2025, $314751.0 for Q3 2025, and -$319625.0 during Q2 2025.